NCT05693545View on ClinicalTrials.gov

GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

1,004

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2027

Conditions
Rheumatic Heart Disease
Interventions
DRUG

phenoxymethyl penicillin

Prophylaxis

DRUG

intramuscular benzathine penicillin G (BPG) prophylaxis

Prophylaxis

Trial Locations (1)

Unknown

RECRUITING

Uganda Heart Institute, Kampala

All Listed Sponsors
collaborator

Uganda Heart Institute

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER